XASX
MVF
Market cap203mUSD
Oct 09, Last price
0.75AUD
1D
-0.67%
1Q
4.20%
Jan 2017
-63.66%
IPO
-58.61%
Name
Monash IVF Group Ltd
Chart & performance
P/E
39.09
P/S
1.08
EPS
0.02
Div yield, %
6.93%
Shrs. gr., 5y
—
Rev. gr., 5y
7.97%
Revenues
269m
-0.90%
Net income
7m
-70.31%
CFO
30m
+134.11%
Dividend
Sep 03, 20260.013 AUD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Founded in 2014 and headquartered in Richmond, Australia, Monash IVF Group Limited delivers specialized reproductive assistance and women's imaging services. Its operations span Australia and Malaysia, offering a broad spectrum of care. This includes diagnostic obstetric and gynecological ultrasound examinations, a range of fertility treatments, and advanced tertiary-level prenatal diagnostics. The company is also a key provider of in-vitro fertilization (IVF) services.
Key people
Independent Chairman of the Board · since 2014
Malik Jainudeen
Chief Financial Officer, Company Secretary · since 2019
Brett Comer
Chief Operating Officer · since 2018
Pierre Abou Haila
Chief Information Officer
Fiona Allen
Chief Marketing Officer
Michael Damian Knaap
Chief Executive Officer, Managing Director, Director · since 2019
Everard Hunder
General Manager Marketing · since 2018
Tom Sexton
General Manager - Queensland
Clementina Singh
General Manager � New South Wales · since 2018
Nicolette Curtis
Regional Manager - Eastern Victoria
Tedd Fuell
Quality, Regulatory & Risk Manager · since 2018
Hamish Hamilton
Regional Manager-South Australia, Northern Territory & Ultrasound · since 2018
Jan Lagerwij
International Business Development Manager
Michelle Lane
Director of Research & Development · since 2018
May Loke
Centre Manager, KL Fertility & Gynaecology Centre
Peggy North
Chief People & Culture Officer · since 2018
Jonathan Whitty
Regional Manager - Western Victoria
Luk Rombauts
Group Medical Director
Independent Non-Executive Director · since 2014
Non-Executive Independent Director · since 2014
IPO date
Jun 26, 2014
Employees
867
Domiciled in
AU
Incorporated in
AU
Valuation
Title AUD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||